Department of Ultrasound, Second Hospital of Tianjin Medical University, Tianjin, China.
Department of Urology, Second Hospital of Tianjin Medical University, Tianjin, China.
Ultrasound Med Biol. 2021 Feb;47(2):236-243. doi: 10.1016/j.ultrasmedbio.2020.09.006. Epub 2020 Nov 4.
We studied the characteristics of contrast-enhanced ultrasound (CEUS) in renal pelvic urothelial carcinomas and explored its performance in assessing microvessel density (MVD) of tumor tissues. We retrospectively analyzed the characteristics of 125 cases, which were confirmed pathologically to be renal pelvic urothelial carcinomas using CEUS. We performed CEUS and found that most tumors presented with an enhanced mode of "slow-in (mean = 16.7 ± 2.6 s, range: 12-25 s), hypo-enhancement and fast-out (mean = 69.3 ± 16.2 s, range: 42-113 s)." However, the wash-in pattern, homogeneity and wash-out pattern observed with CEUS was not correlated with pT stage and grade (p > 0.05). But advanced-pT-stage and high-grade tumors had a higher peak enhancement than early-pT-stage and low-grade tumors (p < 0.01). Peak enhancement obtained with CEUS can be used to evaluate the pT stage and grade of renal pelvic urothelial carcinomas more effectively. The MVD of those tissues was observed using immunohistochemical staining of cluster of differentiation 34 (CD34). MVD in the advanced-pT-stage and high-grade groups was significantly higher than that in the early-pT-stage and low-grade groups (p < 0.01). As tumor pT stage and grade improved, CEUS peak enhancement intensity and MVD of tumors also exhibited an upward trend. CEUS peak enhancement intensity has the potential to determine MVD of renal pelvic urothelial carcinomas.
我们研究了肾盂尿路上皮癌的超声造影(CEUS)特征,并探讨了其评估肿瘤组织微血管密度(MVD)的性能。我们回顾性分析了 125 例经 CEUS 证实为肾盂尿路上皮癌的患者的特征。我们进行了 CEUS 检查,发现大多数肿瘤呈“慢进(平均=16.7±2.6s,范围:12-25s)、低增强和快出(平均=69.3±16.2s,范围:42-113s)”增强模式。然而,CEUS 观察到的灌注模式、均匀性和洗脱模式与 pT 分期和分级无关(p>0.05)。但是,高级别 pT 期和高级别肿瘤的峰值增强高于低级别 pT 期和低级别肿瘤(p<0.01)。CEUS 获得的峰值增强可更有效地评估肾盂尿路上皮癌的 pT 分期和分级。采用 CD34 免疫组化染色观察这些组织的 MVD。高级别 pT 期和高级别组的 MVD 明显高于低级别 pT 期和低级别组(p<0.01)。随着肿瘤 pT 分期和分级的改善,CEUS 峰值增强强度和肿瘤的 MVD 也呈上升趋势。CEUS 峰值增强强度有潜力确定肾盂尿路上皮癌的 MVD。